US · HAVAU
Harvard Ave Acquisition Corporation Unit
Programmatic access: InvestorsCraft Valuation API · catalog
Price · as of 2025
$10.49
Market cap 155.67M
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | — | — |
| P/E | 107.88 | |
| P/B | -7.34 | |
| P/S | — | |
| EV/EBITDA | — | |
| PEG | — | |
| P/TBV | -7.34 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $10.10 |
Historic valuation ratios
Pick a category, then toggle metrics to compare.
Line items
Line items
Line items
About Harvard Ave Acquisition Corporation Unit
Harvard Ave Acquisition Corporation, based in Seoul, South Korea, and established in 2024, is primarily focused on orchestrating strategic business combinations. Its core activities involve facilitating transactions such as mergers, share swaps, asset acquisitions, stock purchases, financial recapitalizations, or corporate reorganizations with other companies or entities. This corporation operates as a division under Copley Square Sponsor Limited.
- CEO
- Sung Hyuk Lee
- Employees
- 2
- Beta
- 0.01
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| HAVAU | Harvard Ave Acquisition C… | $10.49 | 155.67M | — | — | 107.88 | -7.34 | — | — | — | -7.34 | 0.00% | 0.00% | 0.00% | — | — | — | -0.09 | — | 2.34 | 2.04 | — | — | — | — | -4.81% | -2.77 | — | 0.00% | 0.00% | 0.00% | — | -21.05 | — | 3.36 |
| AFJK | Aimei Health Technology C… | $12.05 | 73.77M | — | — | 97.81 | 12.89 | — | -126.44 | — | 12.89 | 0.00% | 0.00% | 0.00% | 2.64% | -2.02% | 2.47% | 0.25 | — | 0.00 | 0.00 | -2.42 | -39.29% | — | -15.94% | -0.55% | -0.17 | -1.37% | 0.00% | 0.00% | 63.02% | -126.44 | -187.00 | — | 14.28 |
| BSAA | BEST SPAC I Acquisition C… | $11.40 | 68.68M | — | — | 46.83 | 12.06 | — | -44.73 | — | 12.06 | 0.00% | 0.00% | 0.00% | — | — | — | 0.00 | — | 9.29 | 8.47 | 1.99 | — | — | — | -1.97% | -3.91 | — | 0.00% | 0.00% | 0.00% | -44.73 | -48.71 | — | 0.32 |
| CPBI | Central Plains Bancshares… | $20.90 | 87.42M | $30.61 | +46% | 17.53 | 0.79 | 2.31 | 0.05 | 186.99 | 0.79 | 69.47% | 16.45% | 13.19% | 4.64% | 36.84% | 0.75% | 0.00 | 0.56 | 1703.58 | 1703.58 | -1.22 | 9.38% | 11.05% | -289.37% | 8.28% | 155.49 | 53.50% | 0.00% | 0.00% | 0.97% | 0.06 | 0.05 | 0.01 | 0.47 |
| EURK | Eureka Acquisition Corp C… | $11.51 | 88M | — | — | 39.96 | -87.60 | — | -64.23 | — | -87.60 | 0.00% | 0.00% | 0.00% | 4.71% | -2.97% | 3.04% | -0.80 | — | 0.14 | 0.07 | -0.52 | -1413.43% | — | 136.78% | -1.22% | -0.92 | -2.31% | 0.00% | 0.00% | 0.00% | -64.23 | -82.56 | — | 45.22 |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $10.49) − 1 = — (IC, example).